EditorialAlong with colleagues, Dr. Joseph Wu, director of the Stanford Cardiovascular Institute, is using CRISPR to draw links between the DNA of individual patients and heart disease. (Nina Riggio/The New York Times)
EditorialMany doctors recommend a coronary calcium scan to pinpoint which patients would benefit from treatment to reduce their cardiovascular risk. (Rachel Levit/The New York Times)